Patents
#1
Patent on platform technology applied to 5-FU prodrug granted in US860399B2 (2013), EP2393472B1(2019), expiration date: 19/03/2030
#2
PCT patent filed on Gemcitabine amphiphile prodrug, PCT/AU2019/050363
#3
PCT patent filed on Platinum-based amphiphile prodrug, PCT/AU2019/050646
CONTACT
Lane Cove West Business Park
Unit 2, 11/13 Orion Road,
Lane Cove West NSW 2066,
Australia
Telephone: +61 2 9418 6050
E-mail: info＠nanomed.com.au